- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant ; volume:14 ; number:1 ; day:6 ; month:12 ; year:2023 ; pages:1-9 ; date:12.2023
Nature Communications ; 14, Heft 1 (6.12.2023), 1-9, 12.2023
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Creator
-
Khan, Khadija
Lustig, Gila
Römer, Cornelius
Reedoy, Kajal
Jule, Zesuliwe
Karim, Farina
Ganga, Yashica
Bernstein, Mallory
Baig, Zainab
Jackson, Laurelle
Mahlangu, Boitshoko
Mnguni, Anele
Nzimande, Ayanda
Stock, Nadine
Kekana, Dikeledi
Ntozini, Buhle
Deventer, Cindy van
Marshall, Terry
Manickchund, Nithendra
Gosnell, Bernadett I.
Lessells, Richard J.
Karim, Quarraisha Abdool
Abdool Karim, Salim S.
Moosa, Mahomed-Yunus S.
Oliveira, Tulio de
Gottberg, Anne von
Wolter, Nicole
Neher, Richard A.
Sigal, Alex
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-43703-3
- URN
-
urn:nbn:de:101:1-2024022214014082201122
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khan, Khadija
- Lustig, Gila
- Römer, Cornelius
- Reedoy, Kajal
- Jule, Zesuliwe
- Karim, Farina
- Ganga, Yashica
- Bernstein, Mallory
- Baig, Zainab
- Jackson, Laurelle
- Mahlangu, Boitshoko
- Mnguni, Anele
- Nzimande, Ayanda
- Stock, Nadine
- Kekana, Dikeledi
- Ntozini, Buhle
- Deventer, Cindy van
- Marshall, Terry
- Manickchund, Nithendra
- Gosnell, Bernadett I.
- Lessells, Richard J.
- Karim, Quarraisha Abdool
- Abdool Karim, Salim S.
- Moosa, Mahomed-Yunus S.
- Oliveira, Tulio de
- Gottberg, Anne von
- Wolter, Nicole
- Neher, Richard A.
- Sigal, Alex
- SpringerLink (Online service)
Other Objects (12)
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Protein‐Based Face Mask with High SARS‐CoV‐2 Neutralization Ability and Breathability
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Protein‐Based Face Mask with High SARS‐CoV‐2 Neutralization Ability and Breathability
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Protein‐Based Face Mask with High SARS‐CoV‐2 Neutralization Ability and Breathability
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
Antibody escape and global spread of SARS-CoV-2 lineage A.27